Photo of Clay Higgins
R United States House · District 3 · Louisiana On the 2026 ballot

Rep. Clay Higgins

Compare
Total votes
2,837
all sessions
Attendance
94%
180 missed
Near the chamber average
With party
87%
of cast votes
Lower than 93% of chamber peers
Bipartisan score
7%
crosses aisle rarely
Higher than 92% of chamber peers
Sponsored
915
bills & resolutions
Near the chamber average
Committees
6
assignments
915 bills and resolutions

Sponsored bills

Total
915
Primary
114
Co-sponsor
801
This page
915
matching current filters
Co-sponsor HR 857
In committee · United States House · Co-sponsor
Presidential Budget Accountability Act

Maddy summaryHR 857, the Presidential Budget Accountability Act, requires the President to submit the annual budget to Congress by the first Monday in February. If the budget is late, federal funds cannot be used for the President's travel expenses starting the Tuesday after that date until the budget is submitted. The bill specifically restricts funds for the President's expense allowance, travel costs, entertainment, and subsistence during travel. This directly affects the President's travel budget and aims to incentivize timely budget submissions by the executive branch.

In committee Feb 7, 2023 1 co-sponsor
Co-sponsor HR 858
In committee · United States House · Co-sponsor
PAYSTUB Act

Maddy summaryThe PAYSTUB Act requires the President to submit the federal budget to Congress by the first Monday in February. If the President misses this deadline, the bill prohibits using federal funds for salaries and expenses of political appointees (including Executive Schedule positions, certain Senior Executive Service roles, and policy-determining Schedule C positions) from the Tuesday after the deadline until the budget is submitted. Affected employees must then be paid retroactively at their standard rate once the budget is filed. This creates a direct financial consequence for the executive branch if the President fails to meet the constitutional budget deadline.

In committee Feb 7, 2023 1 co-sponsor
Co-sponsor HR 828
In committee · United States House · Co-sponsor
TROOP Act

Maddy summaryHR 828, the TROOP Act, allows service members involuntarily separated from the military solely for refusing a COVID-19 vaccine to request reinstatement to their previous rank and grade. It requires the military to provide back pay for the period between separation and reinstatement upon such a request. The bill specifically applies to individuals separated "solely" due to vaccine refusal, as defined in the legislation. It does not create new requirements for vaccination but addresses past separations by restoring pay and status.

In committee Feb 6, 2023 1 co-sponsor
Co-sponsor HR 790
In committee · United States House · Co-sponsor
RIFLE Act

Repealing Illegal Freedom and Liberty Excises Act or the RIFLE Act This bill repeals the excise tax on the transfer of firearms. The bill shall not be construed as placing any regulated firearms under the jurisdiction of the U.S. Consumer Product Safety Commission.

In committee Feb 2, 2023 1 co-sponsor
Co-sponsor HR 139
Passed · United States House · Co-sponsor
SHOW UP Act of 2023

Maddy summaryHR 139, the SHOW UP Act of 2023, requires U.S. federal executive agencies to revert to their pre-pandemic telework policies and levels by January 30, 2024 (30 days after enactment). Agencies must conduct a study on pandemic-era telework impacts - including effects on mission performance, costs from underused offices or incorrect pay classifications, and employee productivity - and submit a new plan to Congress if they seek to expand telework beyond 2019 levels. This plan requires certification from the Office of Personnel Management (OPM) Director confirming it will improve mission performance, reduce real property costs, lower locality pay expenses, and ensure secure remote work tools without increasing overall costs. The bill directly affects all federal executive agencies and their telework policies, mandating a return to pre-2020 practices while creating a formal process for any future telework expansion.

Passed Feb 2, 2023 1 co-sponsor
Co-sponsor HR 646
In committee · United States House · Co-sponsor
SHORT Act

Maddy summaryHR 646, the SHORT Act, clarifies firearm definitions under federal law to exclude antique firearms and certain collector items from the "firearm" category. It removes restrictions on short-barreled rifles and shotguns used lawfully by eliminating specific prohibitions in federal law and preempts state laws imposing taxes or registration requirements on these weapons. The bill also mandates the destruction of federal records related to short-barreled rifles, shotguns, and other weapons defined under the National Firearms Act within 365 days of enactment. This directly affects owners of these specific firearms, particularly collectors and individuals possessing short-barreled weapons legally under federal law. The key mechanisms include revised definitions, federal preemption of state regulations, and record destruction requirements.

In committee Feb 1, 2023 1 co-sponsor
Co-sponsor HR 21
Passed · United States House · Co-sponsor
Strategic Production Response Act

Maddy summaryThe Strategic Production Response Act (HR 21) requires the Secretary of Energy to develop a plan increasing oil and gas leasing on federal lands (managed by Interior, Agriculture, Energy, and Defense) by the same percentage as any initial drawdown of petroleum from the Strategic Petroleum Reserve. This plan must be created before the first sale, exchange, or loan of reserve oil, and cannot increase leasing on federal lands by more than 10% overall. The bill mandates consultation with the Secretaries of Agriculture, Interior, and Defense during plan development. It directly affects federal land management agencies and future oil/gas leasing decisions on public lands.

Passed Jan 30, 2023 1 co-sponsor
Co-sponsor HR 427
In committee · United States House · Co-sponsor
SAVE Moms and Babies Act of 2023

Maddy summaryThis bill would prohibit the FDA from approving new abortion medications or investigational uses of existing ones. It would restrict currently approved abortion drugs to in-person administration only in clinics, hospitals, or medical offices by certified providers who can handle complications like ectopic pregnancy or severe bleeding. The law requires detailed adverse event reporting (excluding patient identifiers) to the FDA by both manufacturers and prescribers, and mandates provider certification covering pregnancy assessment, surgical intervention capabilities, and patient safety documentation. These provisions apply directly to healthcare providers, patients seeking medication abortions, and manufacturers of abortion drugs.

In committee Jan 27, 2023 1 co-sponsor
Co-sponsor HR 383
In committee · United States House · Co-sponsor
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits any similar changes in the future.

In committee Jan 27, 2023 1 co-sponsor
Co-sponsor HR 564
In committee · United States House · Co-sponsor
Saving Taxpayers’ Money and Paying America’s Debt Act

Maddy summaryHR 564 redirects unspent funds from the American Rescue Plan Act of 2021 (ARP) to reduce the federal deficit. It requires all unobligated ARP funds - money allocated but not yet spent - to be sent to the Treasury's general fund upon the bill's enactment. This action directly affects federal budget accounting by canceling unused appropriations rather than creating new programs or aiding specific groups. The bill does not alter existing laws or services but focuses solely on reallocating existing, unspent federal funds. It is a procedural budget measure with no direct impact on taxpayers or beneficiaries of the ARP.

In committee Jan 26, 2023 1 co-sponsor
Showing 661 to 670 of 915 bills
Previous 1 … 66 67 68 … 92 Next